Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 5/20 | 0.44 |
| ▸ | MGAM | O43451 | 1/20 | 0.44 |
| ▸ | SI | P14410 | 1/20 | 0.44 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7101348 | 0.85 | NPSR1 (0.48) | NPSR1GLO1GAAMGAMSI | |
| SCHEMBL7101351 | 0.85 | NPSR1 (0.48) | NPSR1GLO1GAAMGAMSI | |
| SCHEMBL27588446 | 0.82 | NPSR1 (0.42) | NPSR1GLO1GAAMGAMSI | |
| SCHEMBL20210964 | 0.82 | NPSR1 (0.42) | NPSR1GLO1GAAMGAMSI | |
| SCHEMBL14304405 | 0.82 | NPSR1 (0.42) | NPSR1GLO1GAAMGAMSI | |
| SCHEMBL30241757 | 0.81 | GAA (0.44) | NPSR1GLO1GAAMGAMSI | |
| SCHEMBL12283185 | 0.80 | NPSR1 (0.61) | NPSR1GLO1GAAMGAMSI | |
| SCHEMBL28991955 | 0.80 | NPSR1 (0.41) | NPSR1GLO1GAAMGAMSI | |
| SCHEMBL11174724 | 0.79 | NPSR1 (0.43) | NPSR1GLO1GAAMGAMSI | |
| SCHEMBL22574853 | 0.79 | CYP2C9 (0.53) | NPSR1GLO1GAAMGAMSI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106010319-A | Adhesive sheet | 琳得科株式会社 | 2016-10-12 | — | — | CN | disclosed |
| CN-101492589-A | Antifouling paint composition | MITSUBISHI RAYON CO (JP) | 2009-07-29 | — | — | CN | disclosed |
| CN-100473698-C | Antifouling coating composition | MITSUBISHI RAYON CO (JP) | 2009-04-01 | — | — | CN | disclosed |
| CN-1761727-A | Antifouling coating composition | MITSUBISHI RAYON CO (JP) | 2006-04-19 | — | — | CN | disclosed |
| US-20030181515-A1 | Methods of using kavalactone compositions | KAVA PHARMACEUTICALS, INC., A DELAWARE CORPORATION | 2003-09-25 | — | — | US | disclosed |
| US-20020192241-A1 | Methods of using kavalactone compositions | SYNTA PHARMACEUTICALS CORP. | 2002-12-19 | — | — | US | disclosed |
| US-20020187169-A1 | Kavalactone compositions | SYNTA PHARMACEUTICALS CORP. | 2002-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020187169-A1 | Kavalactone compositions | KLK14, KLHL20, KLHL6 | NPSR1 4537/4885GLO1 354/4885GAA 548/4885 |
| US-20030181515-A1 | Methods of using kavalactone compositions | KHK, KLK4, KLK14 | NPSR1 4379/4885GLO1 189/4885GAA 343/4885 |
| US-20020192241-A1 | Methods of using kavalactone compositions | KHK, KLK4, KLK14 | NPSR1 4379/4885GLO1 189/4885GAA 343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.